
Deontics Ltd is a spin-out from Oxford University, University College London, and Cancer Research UK, specializing in clinically-driven AI systems for primary and secondary healthcare. Their proprietary AI platform uses knowledge representation to mimic human clinical decision-making, providing advanced, evidence-based, and transparent treatment recommendations integrated into healthcare workflows via electronic medical records. The platform supports clinical customization without engineering input, ensuring up-to-date localized best practices. Deontics is a certified Class 1 Medical Device, compliant with NHS data security standards, and has been validated in clinical trials including NHSx and NIHR AI in Health and Care Award projects. Their technology improves healthcare standardization, clinical efficiency, and patient outcomes, positioning them as a leader in intelligent healthcare decision support systems.

Deontics Ltd is a spin-out from Oxford University, University College London, and Cancer Research UK, specializing in clinically-driven AI systems for primary and secondary healthcare. Their proprietary AI platform uses knowledge representation to mimic human clinical decision-making, providing advanced, evidence-based, and transparent treatment recommendations integrated into healthcare workflows via electronic medical records. The platform supports clinical customization without engineering input, ensuring up-to-date localized best practices. Deontics is a certified Class 1 Medical Device, compliant with NHS data security standards, and has been validated in clinical trials including NHSx and NIHR AI in Health and Care Award projects. Their technology improves healthcare standardization, clinical efficiency, and patient outcomes, positioning them as a leader in intelligent healthcare decision support systems.
Headquarters: London, United Kingdom
Product: Clinically-driven AI clinical decision support platform (CDSS) for point-of-care treatment recommendations
Founding origins: Spin-out from Oxford University, UCL, and Cancer Research UK (PROforma lineage)
Regulatory / validation: Certified Class 1 Medical Device; validated in NHSx and NIHR clinical projects
Employee count: Approx. 11
Notable investor: Apax Partners (reported)
Clinical decision support and clinical quality for primary and secondary healthcare
Healthtech / Clinical Decision Support
1160000.00 USD
Reported early round in Aug 2014; public profiles record Apax Partners as an investor and amounts vary across sources.
“Apax Partners listed as an investor in reported 2014 round”